Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Interstitial Nephritis | Case report

Renal tubular acidosis without interstitial nephritis in Sjögren’s syndrome: a case report and review of the literature

Authors: Shintaro Hamada, Tomoaki Takata, Kentaro Yamada, Marie Yamamoto, Yukari Mae, Takuji Iyama, Takaaki Sugihara, Miki Takata, Hajime Isomoto

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Renal tubular acidosis is the principal clinical feature associated with tubulointerstitial nephritis in patients with primary Sjögren’s syndrome. Renal tubular dysfunction due to interstitial nephritis has been considered the underlying pathophysiology connecting renal tubular acidosis and primary Sjögren’s syndrome. However, the detailed mechanisms underlying the pathophysiology of renal tubular acidosis in primary Sjögren’s syndrome is not fully understood.

Case presentation

A 30-year-old woman was admitted with complaints of weakness in the extremities. The patient was hospitalized thirteen years earlier for similar issues and was diagnosed with hypokalemic paralysis due to distal renal tubular acidosis with primary Sjögren’s syndrome. This diagnosis was based on a positive Schirmer's test. Besides, anti-Sjögren’s syndrome-related antigen A was also detected. Laboratory tests indicated distal RTA; however, a renal biopsy showed no obvious interstitial nephritis. Laboratory tests conducted during the second admission indicated distal renal tubular acidosis. Therefore, a renal biopsy was performed again, which revealed interstitial nephritis. Histological analysis of acid–base transporters revealed the absence of vacuolar type H+-ATPases in the collecting duct. The vacuolar type H+-ATPase was also absent in the past renal biopsy, suggesting that the alteration in acid–base transporters is independent of interstitial nephritis.

Conclusions

This case study demonstrates that vacuolar-type H+-ATPases are associated with distal renal tubular acidosis, and distal renal tubular acidosis precedes interstitial nephritis in patients with primary Sjögren’s syndrome.
Literature
1.
go back to reference Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C. Current state of knowledge on primary sjögren’s syndrome, an autoimmune exocrinopathy. J Clin Med. 2020;9:2299.CrossRefPubMedPubMedCentral Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C. Current state of knowledge on primary sjögren’s syndrome, an autoimmune exocrinopathy. J Clin Med. 2020;9:2299.CrossRefPubMedPubMedCentral
2.
go back to reference Asmussen K, Andersen V, Bendixen G, Schiødt M, Oxholm P. A new model for classification of disease manifestations in primary Sjögren’s syndrome: Evaluation in a retrospective long-term study. J Intern Med. 1996;239:475–82.CrossRefPubMed Asmussen K, Andersen V, Bendixen G, Schiødt M, Oxholm P. A new model for classification of disease manifestations in primary Sjögren’s syndrome: Evaluation in a retrospective long-term study. J Intern Med. 1996;239:475–82.CrossRefPubMed
3.
go back to reference Rodríguez SJ. Renal tubular acidosis: The clinical entity. J Am Soc Nephrol. 2002;13:2160–70.CrossRef Rodríguez SJ. Renal tubular acidosis: The clinical entity. J Am Soc Nephrol. 2002;13:2160–70.CrossRef
4.
go back to reference Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, et al. Characterization of systemic disease in primary sjögren’s syndrome: EULAR-SS task force recommendations for articular, cutaneous, pulmonary, and renal involvements. Rheumatol (Oxford). 2015;54:2230–8.CrossRef Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, et al. Characterization of systemic disease in primary sjögren’s syndrome: EULAR-SS task force recommendations for articular, cutaneous, pulmonary, and renal involvements. Rheumatol (Oxford). 2015;54:2230–8.CrossRef
5.
go back to reference Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, et al. Clinical and morphological features of kidney involvement in primary Sjögren’s syndrome. Nephrol Dial Transplant. 2001;16:2328–36.CrossRefPubMed Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, et al. Clinical and morphological features of kidney involvement in primary Sjögren’s syndrome. Nephrol Dial Transplant. 2001;16:2328–36.CrossRefPubMed
6.
go back to reference Ren H, Wang WM, Chen XN, Zhang W, Pan XX, Wang XL, et al. Renal involvement and followup of 130 patients with primary Sjögren’s syndrome. J Rheumatol. 2008;35:278–84.PubMed Ren H, Wang WM, Chen XN, Zhang W, Pan XX, Wang XL, et al. Renal involvement and followup of 130 patients with primary Sjögren’s syndrome. J Rheumatol. 2008;35:278–84.PubMed
7.
go back to reference Goules A, Masouridi S, Tzioufas AG, Ioannidis JPA, Skopouli FN, Moutsopoulos HM. Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore). 2000;79:241–9.CrossRefPubMed Goules A, Masouridi S, Tzioufas AG, Ioannidis JPA, Skopouli FN, Moutsopoulos HM. Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore). 2000;79:241–9.CrossRefPubMed
8.
go back to reference Joachim HI, Shlipak MG. The promise of tubule biomarkers in kidney disease: A review. Am J Kidney Dis. 2021;78:719–27.CrossRef Joachim HI, Shlipak MG. The promise of tubule biomarkers in kidney disease: A review. Am J Kidney Dis. 2021;78:719–27.CrossRef
10.
go back to reference Seirafian S, Shafie M, Abedini A, Pakzad B, Roomizadeh P. Recurrent attacks of hypokalemic quadriparesis: an unusual presentation of primary Sjögren syndrome. Intern Med. 2016;55:1797–800.CrossRefPubMed Seirafian S, Shafie M, Abedini A, Pakzad B, Roomizadeh P. Recurrent attacks of hypokalemic quadriparesis: an unusual presentation of primary Sjögren syndrome. Intern Med. 2016;55:1797–800.CrossRefPubMed
11.
go back to reference Evans R, Zdebik A, Ciurtin C, Walsh SB. Renal involvement in primary Sjögren’s syndrome. Rheumatol (Oxford). 2015;54:1541–8.CrossRef Evans R, Zdebik A, Ciurtin C, Walsh SB. Renal involvement in primary Sjögren’s syndrome. Rheumatol (Oxford). 2015;54:1541–8.CrossRef
12.
go back to reference Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:1983–9.CrossRefPubMed Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:1983–9.CrossRefPubMed
13.
go back to reference Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: A cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. 2017;76:1042–50.CrossRefPubMed Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: A cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. 2017;76:1042–50.CrossRefPubMed
14.
go back to reference Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64:347–54.CrossRefPubMed Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64:347–54.CrossRefPubMed
15.
go back to reference Ponticelli C, Doria A, Moroni G. Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases). J Nephrol. 2021;34:1069–80.CrossRefPubMed Ponticelli C, Doria A, Moroni G. Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases). J Nephrol. 2021;34:1069–80.CrossRefPubMed
16.
go back to reference Aasarød K, Haga HJ, Berg KJ, Hammerstrøm J, Jørstad S. Renal involvement in primary sjögren’s syndrome. QJM. 2000;93:297–304.CrossRefPubMed Aasarød K, Haga HJ, Berg KJ, Hammerstrøm J, Jørstad S. Renal involvement in primary sjögren’s syndrome. QJM. 2000;93:297–304.CrossRefPubMed
17.
go back to reference Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjögren’s syndrome: Clinical presentation and outcome. Arthritis Rheum. 2013;65:2945–53.CrossRefPubMed Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjögren’s syndrome: Clinical presentation and outcome. Arthritis Rheum. 2013;65:2945–53.CrossRefPubMed
18.
go back to reference Ranaweerage R, Perera S, Gunapala A. Hypokalaemic paralysis and metabolic alkalosis in a patient with Sjögren syndrome: a case report and literature review. BMC Nephrol. 2021;22:159.CrossRefPubMedPubMedCentral Ranaweerage R, Perera S, Gunapala A. Hypokalaemic paralysis and metabolic alkalosis in a patient with Sjögren syndrome: a case report and literature review. BMC Nephrol. 2021;22:159.CrossRefPubMedPubMedCentral
19.
go back to reference Gu X, Su Z, Chen M, Xu Y, Wang Y. Acquired Gitelman syndrome in a primary Sjögren syndrome patient with a SLC12A3 heterozygous mutation: A case report and literature review. Nephrology. 2017;22:652–5.CrossRefPubMed Gu X, Su Z, Chen M, Xu Y, Wang Y. Acquired Gitelman syndrome in a primary Sjögren syndrome patient with a SLC12A3 heterozygous mutation: A case report and literature review. Nephrology. 2017;22:652–5.CrossRefPubMed
20.
go back to reference François H, Mariette X. Renal involvement in primary Sjögren syndrome. Nat Rev Nephrol. 2016;12:82–93.CrossRefPubMed François H, Mariette X. Renal involvement in primary Sjögren syndrome. Nat Rev Nephrol. 2016;12:82–93.CrossRefPubMed
21.
go back to reference Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, et al. Renal involvement in primary Sjögren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4:1423–31.CrossRefPubMedPubMedCentral Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, et al. Renal involvement in primary Sjögren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4:1423–31.CrossRefPubMedPubMedCentral
22.
go back to reference Igarashi T, Kawamoto H, Kamoshita S. Reversible low-molecular-weight proteinuria in patients with distal renal tubular acidosis. Pediatr Nephrol. 1990;4:953–6.CrossRef Igarashi T, Kawamoto H, Kamoshita S. Reversible low-molecular-weight proteinuria in patients with distal renal tubular acidosis. Pediatr Nephrol. 1990;4:953–6.CrossRef
23.
go back to reference Tolins JP, Hostetter MK, Hostetter TH. Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. J Clin Invest. 1987;79:1447–58.CrossRefPubMedPubMedCentral Tolins JP, Hostetter MK, Hostetter TH. Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. J Clin Invest. 1987;79:1447–58.CrossRefPubMedPubMedCentral
24.
go back to reference Carraro-Lacroix LR, Malnic G. Acid-base transport by the renal distal nephron. J Nephrol. 2010;23:S19-27.PubMed Carraro-Lacroix LR, Malnic G. Acid-base transport by the renal distal nephron. J Nephrol. 2010;23:S19-27.PubMed
25.
go back to reference Mohebbi N, Wagner CA. Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol. 2018;31:511–22.CrossRefPubMed Mohebbi N, Wagner CA. Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol. 2018;31:511–22.CrossRefPubMed
26.
go back to reference Kim HY, Kim SS, Bae EH, Ma SK, Kim SW. Decreased renal expression of H+-ATPase and pendrin in a patient with distal renal tubular acidosis associated with Sjögren’s syndrome. Intern Med. 2015;54:2899–904.CrossRefPubMed Kim HY, Kim SS, Bae EH, Ma SK, Kim SW. Decreased renal expression of H+-ATPase and pendrin in a patient with distal renal tubular acidosis associated with Sjögren’s syndrome. Intern Med. 2015;54:2899–904.CrossRefPubMed
27.
go back to reference Cohen EP, Bastani B, Cohen MR, Kolner S, Henriken P, Gluck SL. Absence of H+-ATPase in cortical collecting tubules of a patient with Sjogren’s syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992;3:264–71.CrossRefPubMed Cohen EP, Bastani B, Cohen MR, Kolner S, Henriken P, Gluck SL. Absence of H+-ATPase in cortical collecting tubules of a patient with Sjogren’s syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992;3:264–71.CrossRefPubMed
28.
go back to reference DeFranco PE, Haragsim L, Schmitz PG, Bastani B. Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sjögren’s syndrome. J Am Soc Nephrol. 1995;6:295–301.CrossRefPubMed DeFranco PE, Haragsim L, Schmitz PG, Bastani B. Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sjögren’s syndrome. J Am Soc Nephrol. 1995;6:295–301.CrossRefPubMed
29.
go back to reference Bastani B, Haragsim L, Gluck S, Siamopoulos KC. Lack of H-ATPase in distal nephron causing hypokalaemic distal RTA in a patient with Sjögren’s syndrome. Nephrol Dial Transplant. 1995;10:908–9.PubMed Bastani B, Haragsim L, Gluck S, Siamopoulos KC. Lack of H-ATPase in distal nephron causing hypokalaemic distal RTA in a patient with Sjögren’s syndrome. Nephrol Dial Transplant. 1995;10:908–9.PubMed
30.
go back to reference Bae EH, Han CW, Lee JH, Park JW, Ma SK, Choi KC, et al. The Case Hypokalemia Associated with nephrocalcinosis. Kidney Int. 2009;75:443–4.CrossRefPubMed Bae EH, Han CW, Lee JH, Park JW, Ma SK, Choi KC, et al. The Case Hypokalemia Associated with nephrocalcinosis. Kidney Int. 2009;75:443–4.CrossRefPubMed
31.
go back to reference Devuyst O, Lemaire M, Mohebbi N, Wagner CA. Autoantibodies against intercalated cells in Sjögren’s syndrome. Kidney Int. 2009;76:229.CrossRefPubMed Devuyst O, Lemaire M, Mohebbi N, Wagner CA. Autoantibodies against intercalated cells in Sjögren’s syndrome. Kidney Int. 2009;76:229.CrossRefPubMed
32.
go back to reference Xu C, Li Y, Ying H, Pan Y, Shi R, Lin X, et al. Presence of serum autoantibodies to vacuolar H+ -ATPase in patients with renal tubular acidosis. Int J Rheum Dis. 2019;22:805–14.CrossRefPubMed Xu C, Li Y, Ying H, Pan Y, Shi R, Lin X, et al. Presence of serum autoantibodies to vacuolar H+ -ATPase in patients with renal tubular acidosis. Int J Rheum Dis. 2019;22:805–14.CrossRefPubMed
Metadata
Title
Renal tubular acidosis without interstitial nephritis in Sjögren’s syndrome: a case report and review of the literature
Authors
Shintaro Hamada
Tomoaki Takata
Kentaro Yamada
Marie Yamamoto
Yukari Mae
Takuji Iyama
Takaaki Sugihara
Miki Takata
Hajime Isomoto
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03290-3

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.